{"AllianceGenome": "6126", "HGNC": "6126", "MIM": "600797", "_id": "8660", "_version": 1, "accession": {"genomic": ["AB000732.1", "AB050954.1", "AF080254.1", "AF288517.1", "AF385932.1", "AF385933.1", "AH008086.2", "AH010223.2", "AL162497.20", "CP068265.2", "HF583735.1", "NC_000013.11", "NC_060937.1", "NG_008154.1"], "protein": ["AAD21531.1", "AAD50546.1", "AAD55239.1", "AAF28976.1", "AAG50013.1", "AAK66750.1", "AAK66751.1", "AAK83053.1", "BAA24500.1", "BAB84688.1", "CCQ43232.1", "NP_003740.2", "Q9Y4H2.2"], "rna": ["AF073310.1", "AF161416.1", "BC012414.1", "BC026044.1", "BC042858.1", "BC063516.1", "BC066356.1", "BC110638.1", "CA416129.1", "CA952668.1", "NM_003749.3"], "translation": [{"protein": "NP_003740.2", "rna": "NM_003749.3"}, {"protein": "AAD21531.1", "rna": "AF073310.1"}, {"protein": "AAF28976.1", "rna": "AF161416.1"}]}, "alias": "IRS-2", "ensembl": {"gene": "ENSG00000185950", "protein": "ENSP00000365016", "transcript": "ENST00000375856", "translation": [{"protein": "ENSP00000365016", "rna": "ENST00000375856"}], "type_of_gene": "protein_coding"}, "entrezgene": "8660", "exons": [{"cdsend": 109786053, "cdsstart": 109756303, "chr": "13", "position": [[109752694, 109756308], [109782041, 109786583]], "strand": -1, "transcript": "NM_003749", "txend": 109786583, "txstart": 109752694}], "exons_hg19": [{"cdsend": 110438400, "cdsstart": 110408650, "chr": "13", "position": [[110405041, 110408655], [110434388, 110438930]], "strand": -1, "transcript": "NM_003749", "txend": 110438930, "txstart": 110405041}], "generif": [{"pubmed": 11030756, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 11481324, "text": "IRS-2, not IRS-1, signals insulin activation of glycogen synthase in the L6hIR skeletal muscle cells. In these cells, insulin inhibition of GSK3 alpha and -beta requires dual phosphorylation by both Akt/PKB and PKC zeta."}, {"pubmed": 11522686, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11600548, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11872698, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12189449, "text": "the 5' flanking sequence of IRS2 was investigated and two single nucleotide polymorphisms (SNPs) were identified; the SNP at -765 was suggested to be involved in the insulin-mediated regulation of the transcriptional activity of IRS2"}, {"pubmed": 12213887, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12213887, "text": "Relationship of genotypes to phenotypic features of polycystic ovary syndrome"}, {"pubmed": 12379806, "text": "Data suggest that insulin receptor substrate-2 (IRS-2) is needed to maintain the predominance of bone formation over bone resorption, whereas IRS-1 maintains bone turnover."}, {"pubmed": 12475767, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12493740, "text": "inhibition of insulin-stimulated insulin receptor substrate (IRS)-phosphatidylinositol 3-kinase/Akt signaling pathway by disrupting the association of IRS-1/IRS-2 with the insulin receptor"}, {"pubmed": 12519871, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12519871, "text": "Polymorphisms of the insulin receptor substrate-2 in patients with type 2 diabetes.  No major role of IRS-2 polymorphisms in the pathogenesis of type 2 diabetes."}, {"pubmed": 12687350, "text": "Mutations in IRS2 gene are associated with severe obesity"}, {"pubmed": 12687350, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12732844, "text": "Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 12765968, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12765968, "text": "the association of homozygosity for the Asp1057 allele in IRS-2 with type 2 diabetes in Pima Indians may be mediated by interaction of the polymorphism with obesity on several diabetes-related traits"}, {"pubmed": 12821935, "text": "IRS-2 is degraded by estrogen receptor alpha and is not involved in IGF-I signaling"}, {"pubmed": 14534541, "text": "Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of IRS2."}, {"pubmed": 14604996, "text": "Both of the IRS proteins modulate VPF/VEGF expression in pancreatic cancer cells by different mechanistic pathways."}, {"pubmed": 14653106, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 14978080, "text": "B cells derived from transgenic mice expressing IRS2 levels elevated by 2- to 3-fold demonstrate alterations in the B cell intrinsic density-dependence of IgE and IgG1 production in vitro and an elevated serum IgE response after in vivo challenge."}, {"pubmed": 15123681, "text": "IRS-2-dependent IL-4 signaling in macrophages is impaired in models of type 2 diabetes mellitus through a mechanism that relies on insulin/glucose-dependent Ser/Thr-Pro motif serine phosphorylation mediated by the mTOR pathway"}, {"pubmed": 15127203, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15155816, "text": "data demonstrate cell-specific alterations in IRS protein concentrations in theca cells from polycystic ovaries consistent with exaggerated amplification of the insulin signal & which may play a role in ovarian hyperandrogenism & thecal hyperplasia"}, {"pubmed": 15247132, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 15247132, "text": "The IRS2 G972R heterozygote GD genotype significantly reduced risk of colon cancer (odds ratio 0.8, 95% CI 0.6-0.9)except for those with the IRS1 R allele."}, {"pubmed": 15292987, "text": "IRS-2/PI 3-kinase pathway does not restore insulin-stimulated glucose uptake in myotubes from Type 2 diabetic patients."}, {"pubmed": 15308584, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15316008, "text": "SH2-B dramatically enhanced leptin-stimulated tyrosine phosphorylation of IRS1 and IRS2 in human and mouse cells."}, {"pubmed": 15678496, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15811564, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15811564, "text": "type 2 diabetic patients, particularly obese patients, carrying the D1057 allele and the CA haplotype were associated with insulin resistance"}, {"pubmed": 15926113, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15940190, "text": "Carriers of Pro allele compared with carriers of Ala allele of PPARG2 gene had higher frequency of insulin resistance. No association was found between insulin resistance and alleles and genotypes of PPAR and IRS2 genes."}, {"pubmed": 15940190, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16030120, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16086274, "text": "Data show that the relationships between G1057D variants of IRS2 and type 2 diabetes mellitus are mediated by obesity."}, {"pubmed": 16086274, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 16127164, "text": "Emergence of IRS-2 overexpression at preneoplastic stages during experimental hepatocarcinogenesis and its protective effect against apoptosis suggest that IRS-2 contributes to liver tumor progression."}, {"pubmed": 16150916, "text": "IRS-1 and -2 degradation are mediated by phosphatidylinositol 3-kinase and proteasome sensitive pathway. High levels of IGF-IR, and possibly the subsequent increase in Akt phosphorylation, are required for efficient IRS degradation."}, {"pubmed": 16448675, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16489531, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16652127, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16839840, "text": "after an acute bout of exercise, insulin-stimulated IRS-2 signaling is enhanced in human skeletal muscle"}, {"pubmed": 17030631, "text": "Transgenic mice overexpressing IRS2 in the mammary gland show progressive mammary hyperplasia, tumorigenesis and metastasis."}, {"pubmed": 17051426, "text": "Genetic variation in IRS2 is associated with breast cancer risk"}, {"pubmed": 17051426, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 17068339, "text": "phosphorylation is a mechanism for regulation of insulin receptor substrate-1/2, Akt, and ERK1/2"}, {"pubmed": 17222321, "text": "We showed that clearance of HCV improves insulin resistance, beta-cell function, and hepatic IRS1/2 expression."}, {"pubmed": 17361103, "text": "This review points out that IRS-2, which is implicated in mediating signals to promote tumor cell survival, growth and motility, is a positive regulator of breast cancer metastasis."}, {"pubmed": 17374994, "text": "This review discusses the roles of IRS-1 and IRS-2 in oncogenic transformation and cancer progression."}, {"pubmed": 17416760, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 17898946, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17901049, "text": "possible regulatory effect of SirT1 on insulin-induced tyrosine phosphorylation of IRS-2, a vital step in insulin signaling pathway, through deacetylation of IRS-2 protein."}, {"pubmed": 17914103, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18059035, "text": "Observational study of gene-disease association, gene-gene interaction, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18079194, "text": "Altered osteoblast proliferation in human osteoporosis may result from dysregulation of IGF-I receptor signaling, including constitutive activation of the IRS-2/Erk signaling pathway."}, {"pubmed": 18506362, "text": "IRS2 expression was localised to macrophages and endothelial cells in vivo. The elevated IRS2 gene expression in macrophages may be associated with an increased risk of CHD."}, {"pubmed": 18506362, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18611262, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18611262, "text": "SNPs in HSD11B1 and IRS2 mark regions of the genome that may harbor risk alleles for breast cancer"}, {"pubmed": 18660489, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18802016, "text": "contribution of defective Irs2 signaling to metabolic syndrome-associated alterations"}, {"pubmed": 18992263, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19038974, "text": "During in-vitro decidualization of cultured human ESCs, levels of IRS-1 increased, suggesting a potential involvement of the IGF signalling pathway in the decidualization process."}, {"pubmed": 19109239, "text": "IL-4 induced highly efficient, gammaC-dependent tyrosine phosphorylation of IRS-2, whereas IL-13 was less effective, even when phosphorylation of STAT6 was maximal"}, {"pubmed": 19124510, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19190347, "text": "Regulatory role of IRS-2 on the expression of IGF-I receptor through Protein kinase c-delta in pancreatic cancer cells."}, {"pubmed": 19259821, "text": "The differential degradation of IRS-1 and IRS-2 contributes to their distinct modes of action."}, {"pubmed": 19332049, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19332049, "text": "These results strongly argue against a major role of the Gly1057Asp IRS-2 polymorphism in the pathogenesis of type 2 diabetes in Djerbian subjects."}, {"pubmed": 19377890, "text": "Study has revealed several new non-synonymous variants in the IRS2 gene in both a cohort of predominately Europid individuals with severe insulin resistance and in insulin-sensitive Europid volunteers."}, {"pubmed": 19447894, "text": "IL-4 can accelerate migration of differentiated airway epithelial cells after injury which requires IRS-1 and/or IRS-2."}, {"pubmed": 19509476, "text": "IRS-2 in osteoblast is up-regulated by E2 and plays important roles in the estrogen- induced bone formation."}, {"pubmed": 19604268, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19690174, "text": "Results identify MAP4K4 as a key upstream mediator of TNF-alpha action on the beta cell, preventing tumor necrosis factor-alpha-induced decrease of IRS-2 and inhibition of glucose-stimulated insulin secretion."}, {"pubmed": 19755487, "text": "A specific region (-688 to -611 bp) was discovered in the IRS2 promoter essential for basal promoter activity and oxidative stress induced transcription depending on ERK activation and SP1 and NFI binding in human hepatocytes."}, {"pubmed": 19818665, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 19875459, "text": "Alternative binding of ZBP89 or SP1 to the described region in the IRS2 promoter regulates neuronal IRS2 expression in a PI3K-dependent manner."}, {"pubmed": 19878940, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19878940, "text": "The insulin receptor substrate G1057D polymorphism may be associated with an increased risk for endometriosis."}, {"pubmed": 19887537, "text": "IRS2 branch of the insulin and IGF signaling is associated with human longevity."}, {"pubmed": 19887537, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19926323, "text": "The association of insulin receptor (IotaNSR) and insulin receptor substrates (IRSs) polymorphisms with the risk of developing polycystic ovary syndrome, was investigated."}, {"pubmed": 19929986, "text": "Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20092705, "text": "In chronic hepatitis B patients the expression and tyrosine phosphorylation of IRS-2 in hepatic tissue were significantly decreased."}, {"pubmed": 20184486, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20184486, "text": "results suggest that insulin receptor substrate-2 G1057D polymorphism may be associated with endometrial cancer"}, {"pubmed": 20210696, "text": "No statistically significant differences in genotypes or allele frequencies for IRS-2 polymorphism were observed between controls and PCOS women."}, {"pubmed": 20210696, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20354165, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20416077, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 20416304, "text": "Observational study of gene-disease association, gene-gene interaction, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20634197, "text": "Meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20685959, "text": "PKR regulates the upstream central transmitters of insulin signaling, IRS1 and IRS2, through different mechanisms."}, {"pubmed": 21042750, "text": "The crosstalk between nuclear IRS-2 and NF-kappaB might be responsible for transcriptional progression of the breast cancer cells."}, {"pubmed": 21045156, "text": "Data suggest that DLX5 plays a significant role in the pathogenesis of some ovarian cancers by enhancing IRS-2-AKT signaling."}, {"pubmed": 21258861, "text": "Evaluation of IRS-2 staining patterns could potentially be used to identify patients with PR- tumors who would most benefit from aggressive treatment."}, {"pubmed": 21325637, "text": "Data show that PDGF-mediated IRS-1/IRS-2 dysregulation resulted in the attenuation of insulin-induced IRS-1/IRS-2-associated PI 3-kinase activity."}, {"pubmed": 21340542, "text": "A-IGF1R/Asp-IRS2/Val-UCP2 allele combination is associated with a decreased all-cause mortality risk and with an increased chance of longevity."}, {"pubmed": 21700708, "text": "Inducible nitric-oxide synthase and nitric oxide donor decrease insulin receptor substrate-2 protein expression by promoting proteasome-dependent degradation in pancreatic beta-cells: involvement of glycogen synthase kinase-3beta."}, {"pubmed": 21771880, "text": "Rare but not common IRS2 variants may play a role in the regulation of body weight but not an essential role in fasting glucose homeostasis in Hispanic children."}, {"pubmed": 21777391, "text": "investigating role of TGFb1IRS2FoxO3a pathway in regulation of E-cadherin in proximal tubule cell: Data suggest that IRS2 expression represses basal E-cadherin expression; IRS2 expression is not required for TGFb1-induced repression of E-cadherin."}, {"pubmed": 21801267, "text": "levels of IL6 were elevated in Polycystic ovary syndrome(PCOS)women compared to normal women; results showed IL6 may be an early low-grade chronic inflammatory marker among polycystic ovary syndrome patients with insulin receptor substrate-2 polymorphism"}, {"pubmed": 21852217, "text": "We genotyped single-nucleotide polymorphisms of IGF1, IGF2, IGF1R, IGF2R, IGFBP1, IGFBP3, IGFBP5, IRS1, IRS2, and IRS in pancreatic cancer patients"}, {"pubmed": 21933986, "text": "Data suggest that the molecular mechanisms for feedback control of IRS signaling to decrease IRS-2 expression in liver and beta-cells are quite distinct, with a predominant role played by FoxO3a in beta-cells."}, {"pubmed": 21984580, "text": "Systemic insulin resistance and subclinical atherosclerosis are associated with decreased IRS2 and TIMP3 expression in circulating monocytes."}, {"pubmed": 22147666, "text": "The rs2289046 polymorphism at the IRS2 gene locus may influence insulin sensitivity by interacting with certain plasma fatty acids in in metabolic syndrome subjects."}, {"pubmed": 22205343, "text": "no association between the IRS-1 and IRS-2 polymorphisms and Polycystic ovary syndrome were found. The results confirm that these polymorphisms should not be considered as major contributors to the pathogenesis of this disorder"}, {"pubmed": 22287730, "text": "Data demonstrate for the first time that IRS2 and FAK may be associated with malignant transformation of neurofibromas."}, {"pubmed": 22465474, "text": "Defective IRS2 expression plays a role in the impaired hematopoietic cell differentiation in myelodysplastic syndrome."}, {"pubmed": 22523112, "text": "No significant associations were observed in IRS-2 Gly1057Asp polymorphism with polycystic ovary syndrome."}, {"pubmed": 22844442, "text": "CASP3 rs4862396, BMP5 rs3734444 and IRS2 rs7986346 may affect the survival in patients after androgen-deprivation therapy for prostate cancer"}, {"pubmed": 22912850, "text": "Amino acids 300-600 of IRS-2 are the 14-3-3 binding region with an important role for IGF-1/insulin-regulated phosphorylation of Ser-573."}, {"pubmed": 22994406, "text": "IRS-2 Gly1057Asp polymorphisms are associated with T2DM in the Kurdish ethnic group."}, {"pubmed": 23018177, "text": "in elderly subjects the presence of the allelic variant Gly1057Asp of IRS2 gene was associated with the degree of insulin resistance and with epicardial fat thickness, suggesting its contribution to global cardiometabolic risk."}, {"pubmed": 23049845, "text": "CaMK4 regulates beta-cell proliferation and apoptosis in a CREB-dependent manner and CaMK4-induced IRS-2 expression is important in these processes"}, {"pubmed": 23147115, "text": "Differential regulation of IRS1 and IRS2 and of their downstream effectors AKT1 and AKT2 is consistent with upregulation of FOXO1"}, {"pubmed": 23216712, "text": "Gly allele at codon 1057 in IRS-2 is correlated with an increased susceptibility to coronary artery disease in the Taiwanese population"}, {"pubmed": 23251408, "text": "IRS-1 to IRS-2 ratios were lower in malignant than in benign prostatic tissue"}, {"pubmed": 23594372, "text": "These data identify IRS2 as a likely driver oncogene in the prevalent 13q34 region of gain/amplification and suggest that IRS2 over-expression may provide an additional mechanism of PI3 kinase pathway activation in colorectal cancer."}, {"pubmed": 23617393, "text": "Upregulation of IRS2 in the kidney tubules of diabetic nephropathy (DN) patients also indicates a novel role for IRS2 as a marker and/or mediator of human DN progression."}, {"pubmed": 23706954, "text": "This study showed that three examined SNPs (rs2059806, Ala550Ala in INSR; rs1801123, Ala804Ala in IRS1; rs4773092, Cys816Cys, IRS2) did not show association with schizophrenia."}, {"pubmed": 24175768, "text": "IRS2 (rs2289046) GG genotype compared with AA+AG genotypes has a protective effect for colorectal cancer in normal weight subjects."}, {"pubmed": 24401133, "text": "These results suggest that IRS-2 1057D allele may be associated with gestational diabetes mellitus."}, {"pubmed": 24497996, "text": "The IRS2 rs1805097 polymorphism is not associated with colorectal and breast cancer risk. [Meta-analysis]"}, {"pubmed": 24616100, "text": "IRS1/2 promotes EMT and cell proliferation through stabilizing Dvl2."}, {"pubmed": 24656929, "text": "IGF-2, IGF-2R, and IRS-2 genes polymorphisms and their combinations are associated with risk of HCC"}, {"pubmed": 24703981, "text": "simulation shows that the wiring of the network determines different functions of IRS1 and IRS2."}, {"pubmed": 24810113, "text": "Increased expression of IRS2 is associated with oral squamous cell carcinoma."}, {"pubmed": 25200290, "text": "Data (including data from knockout mice) suggest reduced insulin/IGF1 (insulin-like growth factor I) signaling slows progressive neurodegeneration of aging and increases life span via mechanism involving IRS2. [REVIEW]"}, {"pubmed": 25283858, "text": "Hepatitis C virus infection triggers endoplasmic reticulum stress and downregulates IRS1 and IRS2 through upregulation of SOCS-3."}, {"pubmed": 25310961, "text": "Study found significant association of the variant of IRS-2 gene as well as the interaction of IRS-1 and IRS-2 genes with polycystic ovary syndrome, especially in non-obese women from Taiwan."}, {"pubmed": 25458098, "text": "Results suggest that a genetic variation in the insulin signaling pathway genes IRS1, IRS2 and INSR may affect the therapeutic response of temporal lobe epilepsy"}, {"pubmed": 25527633, "text": "IRS2 copy number gain, IGF-1R, IR-A, and IGFBP6 RNA expression levels, and KRAS and BRAF mutational status were identified as candidate predictive biomarkers for response to BMS-754807."}, {"pubmed": 25820822, "text": "We conclude that AFB1 may upregulate IRS2 and stimulate lung cancer cell migration through Src"}, {"pubmed": 25830382, "text": "IRS2 phosphorylation is cell cycle-regulated and that Plk1 phosphorylation of IRS2 prevents premature mitotic exit via AKT inactivation."}, {"pubmed": 25959789, "text": "meta-analysis of genetic association studies: Data suggest that the D allele of the G1057D SNP in IRS2 has a significant effect on reducing risk of type 2 diabetes mellitus; obesity is a modifier of this association. [META-ANALYSIS, REVIEW]"}, {"pubmed": 26018509, "text": "These results indicate that miR-106a* affects renal cell carcinoma (RCC) progression by targeting IRS-2 with suppression of the PI3K/Akt signaling pathway in RCC cells"}, {"pubmed": 26040030, "text": "Changes in the expression levels of IRS1, IRS2, RIPK2, RSPO1, and DNA JC15 genes might contribute to the development of insulin resistance and glucose intolerance in the obese boys."}, {"pubmed": 26238771, "text": "These data demonstrate for the first time that miR146a suppresses lung cancer progression by repressing IRS2 expression"}, {"pubmed": 26388164, "text": "FSH decreases IRS-2 mRNA degradation indicating post-transcriptional stabilization."}, {"pubmed": 26508028, "text": "miRNA-146a may function as a useful clinical tool in the treatment and diagnosis of ESCC, and its overexpression suppressed cell growth through inhibition of IRS2."}, {"pubmed": 26684807, "text": "Amplification of CUL4A, IRS2, and TFDP1 genes showed a significant difference in disease-free survival by both univariate and multivariate survival analyses in intrahepatic cholangiocarcinoma."}, {"pubmed": 26755644, "text": "High IRS2 expression is associated with myeloproliferative neoplasms."}, {"pubmed": 26991655, "text": "IRS-specific gene signatures represent accurate surrogates of IGF activity and could predict response to anti-IGF therapy in breast cancer."}, {"pubmed": 27098445, "text": "Findings suggest that insulin receptor substrate -1 Gly972Arg polymorphism is associated with polycystic ovary syndrome in the Caucasian ethnicity, and insulin receptor substrate -2 Gly1057Asp polymorphism is correlated with polycystic ovary syndrome in the Asian ethnicity. However, insulin receptor His 1058 C/T polymorphism may not be implicated in polycystic ovary syndrome."}, {"pubmed": 27247938, "text": "In the renal proximal tubule, insulin signaling via IRS1 is inhibited, while insulin signaling via IRS2 is preserved. Insulin signaling via IRS2 continues to stimulate sodium reabsorption in the proximal tubule and causes sodium retention, edema, and hypertension."}, {"pubmed": 27507812, "text": "Proteasomal inhibition prolonged IRS-2 tyrosine phosphorylation, increased ubiquitination of IRS-2, and enhanced M2 gene expression."}, {"pubmed": 27742835, "text": "these data highlight two novel regulatory proteins that could be therapeutically manipulated to limit IL-4-induced IRS-2 signaling and polarization of M2 macrophages in allergic inflammation."}, {"pubmed": 28126338, "text": "We concluded that USP15 attenuates IGF-I signaling by antagonizing Nedd4-induced IRS-2 ubiquitination."}, {"pubmed": 28212577, "text": "this meta-analysis indicates that IRS-2 gene rs1805097 polymorphism decreased the risk of CRC."}, {"pubmed": 28303061, "text": "Study suggests that polymorphisms of IRS2 putatively participated in the development of pediatric MB development."}, {"pubmed": 28320862, "text": "IRS-1 and IRS-2 signaling interaction with the microtubule cytoskeleton and its response to AKT determines the response to microtubule disruption in breast carcinoma cells"}, {"pubmed": 28360393, "text": "The study results were suggestive of a positive association between Gly972Arg of IRS1 and PCOS in the south Indian population, while INS, IRS2, PPAR-G and CAPN10 failed to show any association with PCOS in our studied population."}, {"pubmed": 28708046, "text": "that MTNR1B and IRS2 gene variants impacted epicardial fat thickness, lipid profile and glucose homeostasis"}, {"pubmed": 29411439, "text": "Insulin signaling pathway protects neuronal cell lines by Sirt3 mediated IRS2 activation."}, {"pubmed": 29610318, "text": "Acute loss of IRS1/IRS2 or inhibition of IR/IGF1R in KRAS-mutant human NSCLC cells decreases the uptake and lowers the intracellular levels of amino acids, while enhancing basal autophagy and sensitivity to autophagy and proteasome inhibitors."}, {"pubmed": 29630758, "text": "The protein-protein docking study of SOCS1 with its natural substrates, IRS1 and IRS2, and subsequent solvent accessible surface area analysis gave insight into the binding region of the SOCS1 protein."}, {"pubmed": 29669935, "text": "IRS2 mutations identified in pleomorphic invasive lobular carcinoma (PILC) enhance invasion, revealing a role for this signaling adaptor in the aggressive nature of PILC."}, {"pubmed": 29685905, "text": "A 174-amino-acid region in the IRS2 C-terminal tail, which is not conserved in IRS1, is required for IRS2-mediated invasion. Importantly, this \"invasion (INV) region\" is sufficient to confer invasion-promoting ability when swapped into IRS1. However, the INV region is not required for the IRS2-dependent regulation of glucose uptake."}, {"pubmed": 29717275, "text": "Studied insulin resistance in human nonalcoholic fatty liver disease patients and controls by analyzing gene expression levels of molecules involved in insulin signaling including insulin receptor substrate 1(IRS-1) and insulin receptor substrate 2(IRS-2)."}, {"pubmed": 29891743, "text": "Urinary sediment cell expression of IRS2 gene was significantly increased in the diabetic nephropathy (DN) patients compared with other groups. In patients with DN, urinary mRNA expression of the IRS2 gene is associated with kidney function."}, {"pubmed": 30165902, "text": "miR-431 inhibits adipogenic differentiation of human mesenchymal stem cells via targeting IRS2."}, {"pubmed": 30295821, "text": "Commutative regulation between endothelial NO synthase and insulin receptor substrate 2 by microRNAs."}, {"pubmed": 30459283, "text": "IRS2 is an adaptor protein that links ALK to neuroblastoma cell survival through the Akt-FoxO3 signaling axis"}, {"pubmed": 30912183, "text": "microRNA-448 inhibits the progression of non-small-cell lung cancer through regulating IRS2."}, {"pubmed": 31009952, "text": "Methylation at CYP2E1 associated with both ASD diagnosis and genotype within the DMR. In contrast, methylation at IRS2 was unaffected by within DMR genotype but modified by preconceptional maternal prenatal vitamin use. This study therefore identified two potentially useful early epigenetic markers for ASD in placenta."}, {"pubmed": 31393907, "text": "Tumors with low IRS-1 and high IRS-2 expression were found to be associated with poor outcomes in adenocarcinoma and squamous cell carcinoma, indicating a potential role for IRS-2 in the aggressive behavior of NSCLC."}, {"pubmed": 31666286, "text": "Night-Shift Work Duration and Risk of Colorectal Cancer According to IRS1 and IRS2 Expression."}, {"pubmed": 31736412, "text": "Circ_0000003 promotes the proliferation and metastasis of non-small cell lung cancer cells via miR-338-3p/insulin receptor substrate 2."}, {"pubmed": 32015092, "text": "Oncogenic ERG Represses PI3K Signaling through Downregulation of IRS2."}, {"pubmed": 32016973, "text": "MiRNA-200a-3p suppresses the proliferation, migration and invasion of non-small cell lung cancer through targeting IRS2."}, {"pubmed": 32540195, "text": "Polymorphism analysis of the Gly972Arg IRS-1 and Gly1057Asp IRS-2 genes in obese pregnant women."}, {"pubmed": 32554797, "text": "The Insulin Receptor Adaptor IRS2 is an APC/C Substrate That Promotes Cell Cycle Protein Expression and a Robust Spindle Assembly Checkpoint."}, {"pubmed": 32603046, "text": "A 3'-untranslated region variant (rs2289046) of insulin receptor substrate 2 gene is associated with susceptibility to nonalcoholic fatty liver disease."}, {"pubmed": 32710190, "text": "Multi-layered epigenetic regulation of IRS2 expression in the liver of obese individuals with type 2 diabetes."}, {"pubmed": 32985705, "text": "Repression of Irs2 by let-7 miRNAs is essential for homeostasis of the telencephalic neuroepithelium."}, {"pubmed": 33012117, "text": "SHP2 knockdown ameliorates liver insulin resistance by activating IRS-2 phosphorylation through the AKT and ERK1/2 signaling pathways."}, {"pubmed": 33421490, "text": "SOX21-AS1 modulates neuronal injury of MMP(+)-treated SH-SY5Y cells via targeting miR-7-5p and inhibiting IRS2."}, {"pubmed": 33570213, "text": "YAP-TEAD up-regulates IRS2 expression to induce and deteriorate oesophageal cancer."}, {"pubmed": 34189964, "text": "The inflammatory role of dysregulated IRS2 in pulmonary vascular remodeling under hypoxic conditions."}, {"pubmed": 34449768, "text": "Association of IRS1 (Gly972Arg) and IRS2 (Gly1057Asp) genes polymorphisms with OSA and NAFLD in Asian Indians."}, {"pubmed": 34605348, "text": "Circular RNA circPRKDC promotes tumorigenesis of gastric cancer via modulating insulin receptor substrate 2 (IRS2) and mediating microRNA-493-5p."}, {"pubmed": 35124585, "text": "Single nucleotide polymorphisms in binding site of miRNA-135a and targeted gene IRS2 are correlated with multiple clinical features of PCOS: A study in Chinese women."}, {"pubmed": 35422233, "text": "MicroRNA-7 Regulates Insulin Signaling Pathway by Targeting IRS1, IRS2, and RAF1 Genes in Gestational Diabetes Mellitus."}, {"pubmed": 35727487, "text": "Structural Consequences of IRS-2 nsSNPs and Implication for Insulin Receptor Substrate-2 Protein Stability."}, {"pubmed": 36631465, "text": "Identification of the ageing-related prognostic gene signature, and the associated regulation axis in skin cutaneous melanoma."}, {"pubmed": 36879410, "text": "Enhancer RNA IRS2e is essential for IRS2 expression and the oncogenic properties in oral squamous cell carcinoma."}, {"pubmed": 37173295, "text": "Association of IRS-1 and IRS-2 polymorphisms with predisposition to type-2 diabetes (T2D): a meta-analysis and trial sequential analysis."}, {"pubmed": 37481466, "text": "Insulin receptor substrate 2 gene Gly1057Asp polymorphism is a risk factor for nonalcoholic fatty liver disease."}, {"pubmed": 37716291, "text": "Influence of polymorphisms in IRS1, IRS2, MC3R, and MC4R on metabolic and inflammatory status and food intake in Brazilian adults: An exploratory pilot study."}, {"pubmed": 37894751, "text": "The IGF-Independent Role of IRS-2 in the Secretion of MMP-9 Enhances the Growth of Prostate Carcinoma Cell Line PC3."}], "genomic_pos": {"chr": "13", "end": 109786583, "ensemblgene": "ENSG00000185950", "start": 109752695, "strand": -1}, "genomic_pos_hg19": {"chr": "13", "end": 110438915, "start": 110406184, "strand": -1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0002053", "qualifier": "involved_in", "term": "positive regulation of mesenchymal cell proliferation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0002903", "qualifier": "involved_in", "term": "negative regulation of B cell apoptotic process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0006006", "pubmed": 9495343, "qualifier": "involved_in", "term": "glucose metabolic process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0007165", "pubmed": 7675087, "qualifier": "involved_in", "term": "signal transduction"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0007420", "qualifier": "involved_in", "term": "brain development"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0008284", "pubmed": 17925406, "qualifier": "involved_in", "term": "positive regulation of cell population proliferation"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0008286", "qualifier": "involved_in", "term": "insulin receptor signaling pathway"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0008286", "qualifier": "involved_in", "term": "insulin receptor signaling pathway"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0009749", "qualifier": "involved_in", "term": "response to glucose"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0010631", "qualifier": "involved_in", "term": "epithelial cell migration"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0010634", "qualifier": "involved_in", "term": "positive regulation of epithelial cell migration"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0010748", "pubmed": 16814735, "qualifier": "involved_in", "term": "negative regulation of long-chain fatty acid import across plasma membrane"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0010907", "pubmed": 16814735, "qualifier": "involved_in", "term": "positive regulation of glucose metabolic process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0019216", "pubmed": 16814735, "qualifier": "involved_in", "term": "regulation of lipid metabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0030879", "qualifier": "involved_in", "term": "mammary gland development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0030890", "qualifier": "involved_in", "term": "positive regulation of B cell proliferation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0032000", "pubmed": 16814735, "qualifier": "involved_in", "term": "positive regulation of fatty acid beta-oxidation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0032024", "qualifier": "involved_in", "term": "positive regulation of insulin secretion"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0032869", "pubmed": 16814735, "qualifier": "involved_in", "term": "cellular response to insulin stimulus"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0033673", "qualifier": "involved_in", "term": "negative regulation of kinase activity"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0044342", "qualifier": "involved_in", "term": "type B pancreatic cell proliferation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0045725", "pubmed": 16814735, "qualifier": "involved_in", "term": "positive regulation of glycogen biosynthetic process"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0045725", "pubmed": 17925406, "qualifier": "involved_in", "term": "positive regulation of glycogen biosynthetic process"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0046326", "pubmed": 16814735, "qualifier": "involved_in", "term": "positive regulation of glucose import"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0051897", "qualifier": "involved_in", "term": "positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0055088", "pubmed": 16814735, "qualifier": "involved_in", "term": "lipid homeostasis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0071333", "qualifier": "involved_in", "term": "cellular response to glucose stimulus"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1901653", "qualifier": "involved_in", "term": "cellular response to peptide"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1904692", "qualifier": "involved_in", "term": "positive regulation of type B pancreatic cell proliferation"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0005829", "qualifier": "is_active_in", "term": "cytosol"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "is_active_in", "term": "plasma membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}], "MF": [{"category": "MF", "evidence": "IEA", "id": "GO:0005068", "qualifier": "enables", "term": "transmembrane receptor protein tyrosine kinase adaptor activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0005158", "qualifier": "enables", "term": "insulin receptor binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [15161933, 15778465, 17901049, 21241768, 23617393, 26496610, 28514442, 36931259], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0019903", "qualifier": "enables", "term": "protein phosphatase binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0019904", "qualifier": "enables", "term": "protein domain specific binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0043548", "qualifier": "enables", "term": "phosphatidylinositol 3-kinase binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0071889", "qualifier": "enables", "term": "14-3-3 protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0141038", "qualifier": "enables", "term": "phosphatidylinositol 3-kinase activator activity"}]}, "homologene": {"genes": [[7955, 393285], [7955, 572001], [8364, 100498409], [9031, 101749060], [9544, 698536], [9598, 452657], [9606, 8660], [9615, 485548], [9913, 100300012], [10090, 384783], [10116, 29376]], "id": 2778}, "interpro": [{"desc": "Pleckstrin homology domain", "id": "IPR001849", "short_desc": "PH_domain"}, {"desc": "IRS-type PTB domain", "id": "IPR002404", "short_desc": "IRS_PTB"}, {"desc": "PH-like domain superfamily", "id": "IPR011993", "short_desc": "PH-like_dom_sf"}, {"desc": "Insulin receptor substrate", "id": "IPR039011", "short_desc": "IRS"}], "ipi": ["IPI00000299", "IPI00464978"], "map_location": "13q34", "name": "insulin receptor substrate 2", "other_names": "insulin receptor substrate 2", "pantherdb": {"HGNC": "6126", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "109334", "ortholog_type": "LDO", "panther_family": "PTHR10614", "taxid": 10090, "uniprot_kb": "P81122"}, {"RGD": "69316", "ortholog_type": "LDO", "panther_family": "PTHR10614", "taxid": 10116, "uniprot_kb": "F1MAL5"}, {"ZFIN": "ZDB-GENE-040426-975", "ortholog_type": "O", "panther_family": "PTHR10614", "taxid": 7955, "uniprot_kb": "F1QHL0"}, {"ZFIN": "ZDB-GENE-081104-462", "ortholog_type": "LDO", "panther_family": "PTHR10614", "taxid": 7955, "uniprot_kb": "A0A0R4IKQ9"}, {"FlyBase": "FBgn0024248", "ortholog_type": "O", "panther_family": "PTHR10614", "taxid": 7227, "uniprot_kb": "Q9XTN2"}], "uniprot_kb": "Q9Y4H2"}, "pathway": {"kegg": [{"id": "hsa04022", "name": "cGMP-PKG signaling pathway - Homo sapiens (human)"}, {"id": "hsa04068", "name": "FoxO signaling pathway - Homo sapiens (human)"}, {"id": "hsa04140", "name": "Autophagy - animal - Homo sapiens (human)"}, {"id": "hsa04152", "name": "AMPK signaling pathway - Homo sapiens (human)"}, {"id": "hsa04211", "name": "Longevity regulating pathway - Homo sapiens (human)"}, {"id": "hsa04213", "name": "Longevity regulating pathway - multiple species - Homo sapiens (human)"}, {"id": "hsa04910", "name": "Insulin signaling pathway - Homo sapiens (human)"}, {"id": "hsa04920", "name": "Adipocytokine signaling pathway - Homo sapiens (human)"}, {"id": "hsa04923", "name": "Regulation of lipolysis in adipocytes - Homo sapiens (human)"}, {"id": "hsa04930", "name": "Type II diabetes mellitus - Homo sapiens (human)"}, {"id": "hsa04931", "name": "Insulin resistance - Homo sapiens (human)"}, {"id": "hsa04932", "name": "Non-alcoholic fatty liver disease - Homo sapiens (human)"}, {"id": "hsa04935", "name": "Growth hormone synthesis, secretion and action - Homo sapiens (human)"}, {"id": "hsa05010", "name": "Alzheimer disease - Homo sapiens (human)"}, {"id": "hsa05206", "name": "MicroRNAs in cancer - Homo sapiens (human)"}], "netpath": [{"id": "Pathway_Alpha6Beta4Integrin", "name": "Alpha6Beta4Integrin"}, {"id": "Pathway_BDNF", "name": "BDNF"}, {"id": "Pathway_EGFR1", "name": "EGFR1"}, {"id": "Pathway_IL-7", "name": "IL-7"}, {"id": "Pathway_IL2", "name": "IL2"}, {"id": "Pathway_IL4", "name": "IL4"}, {"id": "Pathway_Leptin", "name": "Leptin"}], "pid": [{"id": "epopathway", "name": "EPO signaling pathway"}, {"id": "igf1_pathway", "name": "IGF1 pathway"}, {"id": "il2_1pathway", "name": "IL2-mediated signaling events"}, {"id": "il4_2pathway", "name": "IL4-mediated signaling events"}, {"id": "ret_pathway", "name": "Signaling events regulated by Ret tyrosine kinase"}], "reactome": [{"id": "R-HSA-109704", "name": "PI3K Cascade"}, {"id": "R-HSA-112399", "name": "IRS-mediated signalling"}, {"id": "R-HSA-112399", "name": "IRS-mediated signalling"}, {"id": "R-HSA-112412", "name": "SOS-mediated signalling"}, {"id": "R-HSA-112412", "name": "SOS-mediated signalling"}, {"id": "R-HSA-1257604", "name": "PIP3 activates AKT signaling"}, {"id": "R-HSA-1266695", "name": "Interleukin-7 signaling"}, {"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-1280215", "name": "Cytokine Signaling in Immune system"}, {"id": "R-HSA-1280215", "name": "Cytokine Signaling in Immune system"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-166520", "name": "Signaling by NTRKs"}, {"id": "R-HSA-166520", "name": "Signaling by NTRKs"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-187037", "name": "Signaling by NTRK1 (TRKA)"}, {"id": "R-HSA-187037", "name": "Signaling by NTRK1 (TRKA)"}, {"id": "R-HSA-198203", "name": "PI3K/AKT activation"}, {"id": "R-HSA-198203", "name": "PI3K/AKT activation"}, {"id": "R-HSA-199418", "name": "Negative regulation of the PI3K/AKT network"}, {"id": "R-HSA-2219528", "name": "PI3K/AKT Signaling in Cancer"}, {"id": "R-HSA-2219530", "name": "Constitutive Signaling by Aberrant PI3K in Cancer"}, {"id": "R-HSA-2404192", "name": "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"}, {"id": "R-HSA-2404192", "name": "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"}, {"id": "R-HSA-2428924", "name": "IGF1R signaling cascade"}, {"id": "R-HSA-2428924", "name": "IGF1R signaling cascade"}, {"id": "R-HSA-2428928", "name": "IRS-related events triggered by IGF1R"}, {"id": "R-HSA-2428928", "name": "IRS-related events triggered by IGF1R"}, {"id": "R-HSA-2586552", "name": "Signaling by Leptin"}, {"id": "R-HSA-422475", "name": "Axon guidance"}, {"id": "R-HSA-449147", "name": "Signaling by Interleukins"}, {"id": "R-HSA-5663202", "name": "Diseases of signal transduction by growth factor receptors and second messengers"}, {"id": "R-HSA-5673001", "name": "RAF/MAP kinase cascade"}, {"id": "R-HSA-5683057", "name": "MAPK family signaling cascades"}, {"id": "R-HSA-5684996", "name": "MAPK1/MAPK3 signaling"}, {"id": "R-HSA-6811558", "name": "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"}, {"id": "R-HSA-74713", "name": "IRS activation"}, {"id": "R-HSA-74749", "name": "Signal attenuation"}, {"id": "R-HSA-74751", "name": "Insulin receptor signalling cascade"}, {"id": "R-HSA-74751", "name": "Insulin receptor signalling cascade"}, {"id": "R-HSA-74752", "name": "Signaling by Insulin receptor"}, {"id": "R-HSA-74752", "name": "Signaling by Insulin receptor"}, {"id": "R-HSA-8853659", "name": "RET signaling"}, {"id": "R-HSA-9006335", "name": "Signaling by Erythropoietin"}, {"id": "R-HSA-9006335", "name": "Signaling by Erythropoietin"}, {"id": "R-HSA-9006925", "name": "Intracellular signaling by second messengers"}, {"id": "R-HSA-9006934", "name": "Signaling by Receptor Tyrosine Kinases"}, {"id": "R-HSA-9006934", "name": "Signaling by Receptor Tyrosine Kinases"}, {"id": "R-HSA-9027276", "name": "Erythropoietin activates Phosphoinositide-3-kinase (PI3K)"}, {"id": "R-HSA-9027276", "name": "Erythropoietin activates Phosphoinositide-3-kinase (PI3K)"}, {"id": "R-HSA-9027277", "name": "Erythropoietin activates Phospholipase C gamma (PLCG)"}, {"id": "R-HSA-9027283", "name": "Erythropoietin activates STAT5"}, {"id": "R-HSA-9027284", "name": "Erythropoietin activates RAS"}, {"id": "R-HSA-9027284", "name": "Erythropoietin activates RAS"}, {"id": "R-HSA-9675108", "name": "Nervous system development"}, {"id": "R-HSA-982772", "name": "Growth hormone receptor signaling"}], "smpdb": [{"id": "SMP00391", "name": "Insulin Signalling"}, {"id": "SMP00682", "name": "Leucine Stimulation on Insulin Signaling"}], "wikipathways": [{"id": "WP2037", "name": "Prolactin Signaling Pathway"}, {"id": "WP236", "name": "Adipogenesis"}, {"id": "WP2380", "name": "Brain-derived neurotrophic factor (BDNF) signaling pathway"}, {"id": "WP244", "name": "Alpha 6 Beta 4 signaling pathway"}, {"id": "WP2879", "name": "Farnesoid X receptor pathway"}, {"id": "WP2882", "name": "Nuclear Receptors Meta-Pathway"}, {"id": "WP3599", "name": "Transcription factor regulation in adipogenesis"}, {"id": "WP3915", "name": "Angiopoietin Like Protein 8 Regulatory Pathway"}, {"id": "WP3932", "name": "Focal Adhesion-PI3K-Akt-mTOR-signaling pathway"}, {"id": "WP3935", "name": "Leptin Insulin Overlap"}, {"id": "WP395", "name": "IL-4 signaling pathway"}, {"id": "WP4396", "name": "Nonalcoholic fatty liver disease"}, {"id": "WP481", "name": "Insulin Signaling"}, {"id": "WP5066", "name": "FOXA2 pathway"}, {"id": "WP581", "name": "EPO Receptor Signaling"}, {"id": "WP585", "name": "Interferon type I signaling pathways"}]}, "pdb": ["3FQW", "3FQX"], "pfam": ["PF00169", "PF02174"], "pharmgkb": "PA375", "pharos": {"target_id": 2404, "tdl": "Tbio"}, "prosite": ["PS50003", "PS51064"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF258971", "relationship": "is"}, {"id": "GNF258972", "relationship": "is"}, {"id": "GNF258973", "relationship": "is"}, {"id": "GNF258974", "relationship": "is"}], "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF084766", "relationship": "is"}, {"id": "GNF084767", "relationship": "is"}, {"id": "GNF084768", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF053563", "relationship": "is"}, {"id": "GNF058333", "relationship": "is"}, {"id": "GNF073542", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF071271", "relationship": "is"}, {"id": "GNF071272", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF100367", "relationship": "is"}, {"id": "GNF140022", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000013.11", "NC_060937.1", "NG_008154.1"], "protein": "NP_003740.2", "rna": "NM_003749.3", "translation": {"protein": "NP_003740.2", "rna": "NM_003749.3"}}, "reporter": {"HG-U133_Plus_2": ["209184_s_at", "209185_s_at"], "HG-U95Av2": ["40180_at", "40181_f_at"], "HG-U95B": "56338_at", "HTA-2_0": "TC13000871.hg.1", "HuEx-1_0": "3525234", "HuGene-1_1": "7972745", "HuGene-2_1": "16780917"}, "retired": [90066, 113071, 115972], "summary": "This gene encodes the insulin receptor substrate 2, a cytoplasmic signaling molecule that mediates effects of insulin, insulin-like growth factor 1, and other cytokines by acting as a molecular adaptor between diverse receptor tyrosine kinases and downstream effectors. The product of this gene is phosphorylated by the insulin receptor tyrosine kinase upon receptor stimulation, as well as by an interleukin 4 receptor-associated kinase in response to IL4 treatment. [provided by RefSeq, Jul 2008].", "symbol": "IRS2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1334141"}, "unigene": "Hs.442344", "uniprot": {"Swiss-Prot": "Q9Y4H2", "TrEMBL": "Q9P084"}, "wikipedia": {"url_stub": "IRS2"}}